全球細胞庫外包市場規模、佔有率、成長分析（按類型、最終用戶）- 產業預測，2024-2031 年

Global Cell Banking Outsourcing Market Size, Share, Growth Analysis, By Type(Master Cell Banking and Working Cell Banking), By End-User(Biopharmaceutical Companies and Contract Research Organizations (Cros).) - Industry Forecast 2024-2031

出版日期: 2024年03月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

在預測期內（2024-2031年），細胞庫外包的全球市場規模預計為2022年的106億美元，從2023年的123.4億美元成長到2031年的415.8億美元。預計複合年成長率為16.40 %。

在多種因素的推動下，全球細胞庫外包市場將在未來幾年顯著成長。對單株抗體和高效生物治療藥物的需求不斷成長，以及冷凍保存和細胞庫製備的技術進步，推動了幹細胞療法日益普及的程度。根據 CellTrials.org 報導，2020 年第一季先進細胞療法新臨床試驗的全球註冊量激增近 30%，推動了對細胞銀行服務的需求。此外，有利的政府措施以及細胞株保存和表徵新技術的出現預計將進一步推動市場擴張。值得注意的是，市場上的主要企業正在進行合作研究以推動成長。這方面的一個例子是 Opsis Therapeutics、FUJIFILM Cellular Dynamics 和 Blue Rock Therapeutics 於 2021 年 5 月合作開發用於治療眼科疾病的現成 iPSC。最近的研究表明，人類 iPS 細胞具有改善視力和血管健康的潛力，例如印第安納大學醫學院於 2022 年 3 月主導的一項研究，顯示了改善與 2 型糖尿病相關的血管健康併發症的潛力。細胞庫的管理此外，正在進行的旨在維持冷凍保存過程中組織穩定性的冷凍保護劑研究預計將推動市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

龍沙Group Limited（瑞士）
SGS SA（瑞士）
查爾斯河實驗室國際有限公司（美國）
藥明康德（中國）
Eurofins Scientific（盧森堡）
默克公司（德國）
BioReliance 公司（美國）
Toxikon 公司（美國）
GlobalStem（美國）
Paragon Bioservices, Inc.（美國）
BSL Bioservice 科學實驗室有限公司（德國）
ATCC（美國）
BioOutsource 有限公司（英國）
ViruSure 有限公司（奧地利）
賽多利斯股份公司（德國）
賽默飛世爾科技公司（美國）
科文斯公司（美國）
TATAA Biocenter AB（瑞典）
澳洲細胞銀行
StemExpress, LLC（美國）

簡介目錄

Product Code: SQMIG35D2076

Global Cell Banking Outsourcing Market size was valued at USD 10.60 billion in 2022 and is poised to grow from USD 12.34 billion in 2023 to USD 41.58 billion by 2031, growing at a CAGR of 16.40% during the forecast period (2024-2031).

The global cell banking outsourcing market is poised for substantial growth in the forthcoming years, buoyed by various factors. A significant driver is the advancing techniques in cryopreservation and cell bank preparation, alongside the escalating adoption of stem cell therapies and mounting demand for monoclonal antibodies and efficient biopharmaceuticals. With global enrollments of new trials in advanced cell therapy surging by nearly 30% in the initial quarter of 2020, as reported by CellTrials.org, there's evident growing demand for cell banking services. Furthermore, favorable government initiatives and the advent of novel technologies for cell line storage and characterization are anticipated to further fuel market expansion. Notably, key market players are engaging in research collaborations to drive growth, exemplified by Opsis Therapeutics, FUJIFILM Cellular Dynamics, and Blue Rock Therapeutics joining forces in May 2021 to develop off-the-shelf iPSCs for ocular disease treatment. Recent studies, like the one led by the Indiana University School of Medicine in March 2022, showcasing the potential of human-induced pluripotent stem cells in improving visual acuity and vascular health, underscore the significance of stem cell banking in managing vascular health complications linked to type 2 diabetes. Moreover, ongoing research into cryoprotective agents aimed at preserving tissue stability during cryopreservation is expected to be another catalyst for market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segmental Analysis

Global Cell Banking Outsourcing market is segmented by type, end-user, and region. Based on type, the market can be segmented into master cell banking, and working cell banking. Based on end-user, the market is segmented into biopharmaceutical companies and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Cell Banking Outsourcing Market

The escalating adoption of stem cell therapies stands as a significant catalyst propelling the global cell banking outsourcing market forward. Stem cell therapy, a swiftly advancing sector within regenerative medicine, holds promise in addressing various diseases and disorders. With the expanding demand for such therapies, there arises a pressing need for reliable and top-tier cell lines, thereby fueling the requirement for cell banking services. Consequently, this surge in demand is spurring the growth of the cell banking outsourcing market, as biopharmaceutical firms and CROs pursue streamlined and economical avenues for the production and preservation of these invaluable cell lines.

Restraints in the Global Cell Banking Outsourcing Market

One of the primary challenges facing the global cell banking outsourcing market is the substantial expense associated with cell banking services. The rigorous testing and characterization essential for guaranteeing the safety and quality of cell lines necessitate substantial investments in specialized equipment and infrastructure, consequently elevating service costs. Moreover, stringent regulations enforced by regulatory authorities pertaining to cell line production and storage further contribute to the overall expenses. These high costs might hinder the widespread adoption of such services, particularly in developing regions where healthcare budgets are constrained.

Market Trends of the Global Cell Banking Outsourcing Market

One notable trend in the cell banking outsourcing sector is the rising interest in personalized medicine, which seeks to deliver tailored treatments according to each patient's genetic composition. Achieving this goal involves utilizing cells customized to individual requirements. To meet this demand, cell banking outsourcing firms are directing investments towards technologies capable of producing genetically matched cells for patients. This trend is projected to fuel market expansion, reflecting the growing demand for personalized medical solutions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cell Banking Outsourcing Market by Type

Market Overview
Master Cell Banking and Working Cell Banking

Global Cell Banking Outsourcing Market by End-User

Market Overview
Biopharmaceutical Companies and Contract Research Organizations (Cros).

Global Cell Banking Outsourcing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioReliance Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toxikon Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlobalStem (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paragon Bioservices, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSL Bioservice Scientific Laboratories GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATCC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioOutsource Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViruSure GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TATAA Biocenter AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellBank Australia (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StemExpress, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments